All news

SI-BONE grows Q3 revenue 14.5% to $55.7 million and reaffirms 2026 sales guide

GlobeNewswire · · AI-summarised by FinFlash

SI-BONE reported third-quarter worldwide revenue of $55.7 million, up 14.5% from $48.7 million, helped by US procedure volumes rising about 19.5%. Gross margin slipped to 79.3% from 79.8%, and the net loss narrowed to $3.6 million, or $0.08 a share. The medical device maker kept its 2026 revenue forecast at $231 million to $233 million and lowered expected operating expense growth to about 10.5% from 12%.

So What?

Lower expense growth points to better operating leverage for the small-cap spine implant maker. New inpatient payment codes for complex spinal fusion are the next driver to monitor.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.